Skip to content

Clinical trials

Completed Adenocarcinoma of Lung trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Adenocarcinoma of Lung Status: Completed Country / region: United States Clear all

120 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20005
20017
20026
20033
200410
20059
20066
20078
20086
20095
20102
20116
20124
20135
20145
20152
20162
20173
20191
20201
20211
20221

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed120

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Alliance for Clinical Trials in Oncology21
National Cancer Institute (NCI)14
SWOG Cancer Research Network9
Radiation Therapy Oncology Group8
Memorial Sloan Kettering Cancer Center6
Wake Forest University Health Sciences6
Novartis Pharmaceuticals4
Mayo Clinic3
Roswell Park Cancer Institute3
University of Washington3

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Adenocarcinoma of Lung120
Carcinoma, Non-Small-Cell Lung105
Lung Neoplasms88
Adenocarcinoma, Bronchiolo-Alveolar48
Neoplasms6
Colonic Neoplasms5
Breast Neoplasms4
Carcinoma, Ovarian Epithelial4
Neoplasm Metastasis4
Ovarian Neoplasms4

Trials

Showing 1 to 25 of 120. Each trial links to its page on Pharma Observatory.

20 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.